Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats

Microsurgery

Volumn 28, Issue 4, 2008, Pages 285-290

  Zhang, Wei ^a   Zhu, Weiming ^a   Zhang, Jian ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN 1; ENDOTOXIN; GLUCAGON LIKE PEPTIDE 2; INTERLEUKIN 6; LACTIC ACID; MALONALDEHYDE; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM COLONY; CONTROLLED STUDY; DRUG MECHANISM; INTESTINE ISCHEMIA; LAPAROTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; ENDOTOXINS; GLUCAGON-LIKE PEPTIDE 2; INTERLEUKIN-6; INTESTINAL MUCOSA; ISCHEMIC PRECONDITIONING; MALE; MALONDIALDEHYDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44449173093     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20491     Document Type: Article

References (33)

1. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004;49:1359-1377.
2. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: An interface between health and disease. J Gastroenterol Hepatol 2003;18:479-497.
3. Sun Z, Wang X, Deng X, Borjesson A, Wallen R, Hallberg E, Andersson R. Phagocytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and reperfusion injury. Shock 2000;13:209-216.
4. Schoenberg MH, Poch B, Younes M, Schwarz A, Baczako K, Lundberg C, Haglund U, Beger HG. Involvement of neutrophils in postischaemic damage to the small intestine. Gut 1991;32:905-912.
5. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M. The role of tumor necrosis factor-alpha and interleukin-1 beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res 2001;99:134-141.
6. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996;93:7911-7916.
7. Rajeevprasad R, Alavi K, Schwartz MZ. Glucagonlike peptide 2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury. J Pediatr Surg 2000;35:1537-1539.
8. Guan L, Gong D, Tian N, Zou Y. Uncoupling protein 2 involved in protection of glucagon-like peptide 2 in small intestine with ischemia-reperfusion injury in mice. Dig Dis Sci 2005;50:554-560.
9. Riaz AA, Wan MX, Schafer T, Dawson P, Menger MD, Jeppsson B, Thorlacius DH. Allopurinol and superoxide dismutase protect against leucocyte-endothelium interactions in a novel model of colonic ischemia-reperfusion. Br J Surg 2002;89:1572-1580.
10. Granger DN, Hollwarth ME, Parks DA. Ischemia reperfusion injury: Role of oxygen-derived free radicals. Acta Physiol Scand Suppl 1986;548:47-63.
11. Kaszaki J, Wolfard A, Szalay L, Boros M. Pathophysiology of ischemia-reperfusion injury. Transplant Proc 2006;38:826-828.
12. Cameron HL, Perdue MH. Stress impairs murine intestinal barrier function: Improvement by glucagon-like peptide-2. J Pharmacol Exp Ther 2005;314:214-220.
13. Alavi K, Schwartz WZ, Palazzo JP, Prasad R. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J Pediatr Surg 2000;35:847-851.
14. Stephens J, Stoll B, Cottrell J, Chang X, Helmrath M, Burrin DG. Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. Am J Physiol Regul Integr Comp Physiol 2006;290:R283-R289.
15. Oktar BK, Gulpinar MA, Bozkurt A, Ghandour S, Cetinel S, Moini H, Yegen BC, Bilsel S, Granger DN, Kurtel H. Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: Role of blood flow. Am J Physiol Gastrointest Liver Physiol 2002;282:G647-G655.
16. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478-483.
17. Medeiros AC, Chacon DA, Sales VS, Egito ES, Brandao-Neto J, Pinheiro LA, Carvalho MR. Glucan and glutamine reduce bacterial translocation in rat subjected to intestinal ischemia-reperfusion. J Invest Surg 2006;19:39-46.
18. Brandt RB, Siegel SA, Waters MG, Bloch MH. Spectrophotometric assay for D-lactate in serum. Anal Biochem 1980;102:39-46.
19. Luo T, Xia Z. A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in inducing human vascular endothelial cell apoptosis: Reversal with propofol. Anesth Analg 2006;103:110-116.
20. Xia Z, Gu J, Ansley DM, Xia F, Yu J. Antioxidant therapy with Salvia miltiorrhiza decreases serum endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 2003;126:1404-1410.
21. Dowdall JF, Winter DC, Bouchier-Hayes DJ. Inosine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res 2002;108:61-68.
22. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 1999;90:266-275.
23. Murray MJ, Barbose JJ, Cobb CF. Serum D-lactate levels as a predictor of acute intestinal ischemia in a rat model. J Surg Res 1993;54:507-509.
24. Kouris GJ, Liu Q, Rossi H, Djuricin G, Gattuso P, Nathan C, Weinstein RA, Prinz RA. The effect of glucagon-like peptide-2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg 2001;181:571-575.
25. Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 2000;47:112-119.
26. Nalini S, Mathan MM, Balasubramanian KA. Oxygen free radical induced damage during intestinal ischemia/reperfusion in normal and xanthine oxidase deficient rats. Mol Cell Biochem 1993;124:59-66.
27. Beutler B, Cerami A. Cachectin: More than a tumor necrosis factor. N Engl J Med 1987;316:379-385.
28. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987;38:417-432.
29. Wong GG, Clark SC. Multiple actions of interleukin-6 within a cytokine network. Immunol Today 1988;9:137-139.
30. Zanetti G, Heumann D, Gerain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP, Baumgartner JD. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol 1992;148:1890-1897.
31. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP. Prognostic values of tumor necrosis factor/cachectin. interleukin-1, interferon-alpha and interferon-gamma in the serum of patients with septic shock. J Infect Dis 1990;161:982-987.
32. Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model.J Cardiovasc Pharmacol 1998;31:S541-544.
33. Nankervis CA, Schauer GM, Miller CE. Endothelin-mediated vasoconstriction in postischemic newborn intestine. Am J Physiol Gastrointest Liver Physiol 2000;279:G683-G691.